NICE recommends targeted treatment for neuroendocrine cancer in the liver
Posted:
People with neuroendocrine tumours (NETs) in the liver could benefit from a therapy that targets tumours with radiation while limiting exposure to healthy surrounding tissue, according to new guidance from the National Institute for Health and Care Excellence (NICE). NETs are cancers of neuroendocrine cells commonly spread from organs such as the gastrointestinal tract or pancreas to the liver. The guidance is significant as it offers another option for healthcare professionals to treat patients within the National Health Service in England and Wales.
Rapid Health’s Smart Triage innovation newly integrated into the NHS App, is improving GP access for patients across England.
Every patient using Smart Triage that requires an appointment, is offered an average of 61 appointment slots to choose from.
Read more…
A new artificial intelligence (AI) model uses a dual approach to simultaneously analyze different views of CT scans, resembling how doctors work, but without the need to switch between perspectives.
Early diagnosis of lung cancer is crucial, as it significantly improves…
Attendees
Sponsors and Exhibitors
Contact us